178 related articles for article (PubMed ID: 6815107)
1. Treatment of benign fibrocystic disease of the breast with 2-bromo-alpha-ergocryptine (CB 154).
Santoro C; Cappa M; Moretti C; Fabbri A; La Vecchia V; Romano Marcellino L; Fraioli F
Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):479-81. PubMed ID: 6815107
[TBL] [Abstract][Full Text] [Related]
2. Treatment of fibrocystic disease of the breast with a prolactin inhibitor: 2-Br-alpha-ergocryptine (CB-154).
Martin-Comin J; Pujol-Amat P; Cararach V; Davi E; Robyn C
Obstet Gynecol; 1976 Dec; 48(6):703-6. PubMed ID: 1036613
[TBL] [Abstract][Full Text] [Related]
3. Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia treatment.
Rea N; Bove F; Gentile A; Parmeggiani U
Minerva Med; 1997 Nov; 88(11):479-87. PubMed ID: 9433398
[TBL] [Abstract][Full Text] [Related]
4. [Clinical experience with danazol treatment of endometriosis and mastopathy].
Pavelka R; Schneider WH
Wien Klin Wochenschr; 1981 Oct; 93(19):595-9. PubMed ID: 6798763
[TBL] [Abstract][Full Text] [Related]
5. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
Dickey RP; Stone SC
Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
[TBL] [Abstract][Full Text] [Related]
6. Effect of a low-fat diet on hormone levels in women with cystic breast disease. I. Serum steroids and gonadotropins.
Rose DP; Boyar AP; Cohen C; Strong LE
J Natl Cancer Inst; 1987 Apr; 78(4):623-6. PubMed ID: 3104646
[TBL] [Abstract][Full Text] [Related]
7. [Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline].
Mussa A; Sandrucci S; Dogliotti L
Minerva Med; 1979 Nov; 70(51):3493-8. PubMed ID: 522987
[TBL] [Abstract][Full Text] [Related]
8. Serum hormones in human breast cancer subjects.
Krishnamoorthy G; Govindarajulu P; Ramalingam V
Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392
[TBL] [Abstract][Full Text] [Related]
9. Histologic changes in fibrocystic breast disease before and after treatment with bromocriptine.
Murta EF; de Freitas MM; Velludo MA
Rev Paul Med; 1992; 110(6):251-6. PubMed ID: 1341021
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of danazol treatment of women with fibrocystic disease of breast].
Baranowska B; Stopińska-Głuszak U
Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):771-3. PubMed ID: 2701752
[TBL] [Abstract][Full Text] [Related]
11. Treatment of benign breast disease with bromocriptine.
Mussa A; Dogliotti L
J Endocrinol Invest; 1979; 2(1):87-91. PubMed ID: 489922
[TBL] [Abstract][Full Text] [Related]
12. Danazol treatment of chronic cystic mastopathy: a clinical and hormonal evaluation.
Dhont M; Delbeke L; van Eyck J; Voorhoof L
Postgrad Med J; 1979; 55 Suppl 5():66-70. PubMed ID: 395523
[TBL] [Abstract][Full Text] [Related]
13. [Bromocriptine in fibro-cystic mastopathy].
Marzetti L; Framarino ML; Dei Malatesta ML; Aragona C; De Angelis R
Riv Ital Ginecol; 1980; 59(4-5):357-64. PubMed ID: 7313397
[No Abstract] [Full Text] [Related]
14. Benign breast disease.
Mauvais-Jarvis P; Kuttenn F
Curr Ther Endocrinol Metab; 1994; 5():364-70. PubMed ID: 7704754
[No Abstract] [Full Text] [Related]
15. [The concentrations of prolactin and estrogens in women with fibrocystic changes in the breast].
Sieja K; Stanosz S
Ginekol Pol; 2002 Jul; 73(7):594-9. PubMed ID: 12375569
[TBL] [Abstract][Full Text] [Related]
16. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
England PC; Sellwood RA; Knyba RE; Irvine JD
Clin Oncol; 1981 Sep; 7(3):213-9. PubMed ID: 6211319
[No Abstract] [Full Text] [Related]
17. [Hormonal correlations in uterine myoma, internal endometriosis and diffuse mastopathy in patients with a retained biphasic menstrual cycle].
Sokolova ZP
Akush Ginekol (Mosk); 1982 Jun; (6):15-9. PubMed ID: 6812446
[No Abstract] [Full Text] [Related]
18. [Treatment of benign breast pathology with bromocriptine].
Tolino A; Cardone A; Mastrantonio P; Chiacchio G
Riv Ital Ginecol; 1977; 58(5):371-8. PubMed ID: 555037
[No Abstract] [Full Text] [Related]
19. Treatment of premenstrual tension syndrome with bromocriptine.
Andersch B; Hahn L; Wendestam C; Ohman R; Abrahamsson L
Acta Endocrinol Suppl (Copenh); 1978; 216():165-74. PubMed ID: 347860
[No Abstract] [Full Text] [Related]
20. [Results of chronic treatment with bromocriptine in patients with fibrocystic mastopathy].
Ablanedo J; Canales ES
Arch Invest Med (Mex); 1988; 19(3):225-9. PubMed ID: 3242433
[No Abstract] [Full Text] [Related]
[Next] [New Search]
